---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-328226"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2021-11-12T23:59:59+00:00"
generated_at: "2026-06-28T09:30:45.581759+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Rani Therapeutics elects Lyn Baranowski to Board, grants 31,695 stock options

## Summary
- Lyn Baranowski elected as Director effective Nov 10, 2021; term expires at next annual meeting.
- Appointed to Compensation Committee and Nominating and Corporate Governance Committee.
- Granted options to purchase 31,695 shares of Class A common stock at $26.78 (closing price on grant date).
- Options vest over 3 years: one-third at first anniversary, then monthly installments, subject to continuous service.
- Ms. Baranowski has no arrangement with others for her election, and no material interest in transactions requiring disclosure.

## SEC filing metadata
- accession: 0001193125-21-328226
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2021-11-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/0001193125-21-328226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/d626673d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-328226
- JSON: https://secwatch.observer/filing/0001193125-21-328226.json
- Plain text: https://secwatch.observer/filing/0001193125-21-328226.txt

## Key facts
- Executive change
  Lyn Baranowski was elected as Director at Rani Therapeutics Holdings, Inc..
  - Action: elected
  - Role: Director
  source text: On November 10, 2021, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of Rani Therapeutics Holdings, Inc. (the “Company”) elected Lyn Baranowski as a Director, effective immediately, with a term expiring at the Company’s next annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/0001193125-21-328226-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.